Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
International Journal of Cancer|February 14, 2013
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrenceMario Roselli, Patrizia Ferroni, Silvia Riondino, et al.Rejuvenation Research|March 26, 2013
Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancerMatteo Vergati, David Della-Morte, Patrizia Ferroni, et al.International Journal of Oncology|July 13, 2005
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugsLucio Tentori, Matteo Vergati, Alessia Muzi, et al.Molecular Pharmacology|December 19, 2002
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitorLucio Tentori, Ilaria Portarena, Marcella Barbarino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphomaLucio Tentori, Carlo Leonetti, Marco Scarsella, et al.International Journal of Cancer|July 22, 2014
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratioPatrizia Ferroni, Silvia Riondino, Vincenzo Formica, et al.Vaccine|May 17, 2011
Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cellsVittore Cereda, Matteo Vergati, Ngar-Yee Huen, et al.The Oncologist|July 13, 2013
Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancerRavi A Madan, Kwong-Yok Tsang, Marijo Bilusic, et al.European Journal of Cancer (Oxford, England : 1990)|November 18, 2005
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomideLucio Tentori, Carlo Leonetti, Marco Scarsella, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2010
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccinationMatteo Vergati, Vittore Cereda, Ravi A Madan, et al.Pageof 4